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ABSTRACT
The effects of Friend erythroleukemia cells on angiogenesis were studied in chick embryo chorioallantoic
membrane assay and in human umbilical vein endothelial cells. In chorioallantoic membrane assay, the
conditioned medium of Friend cells stimulated in vivo angiogenesis to an extent comparable to that observed
with Prostaglandin E1, used as positive control. Prostaglandin E1 added to conditioned medium of Friend
cells did not further increase angiogenesis. Conditioned medium of Friend erythroleukemia cells also
stimulated proliferation of human umbilical vein endothelial cells to an extent comparable to that observed
with fetal bovine serum, used as positive control. Conditioned medium and fetal bovine serum together did
not affect human umbilical vein endothelial cells proliferation, as compared to that observed when tested
separately. These results seem to indicate that Friend erythroleukemia cells produce and secrete factors
stimulating angiogenesis. These findings extend and confirm the hypothesis that successful angiogenesis is
necessary for development of leukemias.
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INTRODUCTION
Angiogenesis is a prerequisite for sustained
growth of primary tumors and metastases.
Angiogenesis is different from
vasculogenesis as this latter is a biologic
process by which new blood vessels
originate from endothelial cell precursors,
whereas in angiogenesis, new blood vessels
originate from pre-existing blood vessels
(Yancopoulos et al., 1998). Angiogenesis
occurs both in physiologic and pathologic
conditions, and tumor cells as well as normal
growing cells produce and secrete several
growth factors and signaling molecules
involved in the control of angiogenesis.
Among the signals controlling
angiogenesis, prostaglandins play a major
role. An example is represented by
Prostaglandin E1 (PGE1), which induces
angiogenesis by stimulating transcription of
the genes coding for the Vascular
Endothelial Growth Factor (VEGF) and of
other pro-angiogenic factors, such as basic
Fibroblast Growth Factor (bFGF) and
Transforming Growth Factor-β (TGF-β)
and interleukin 6 (IL6) (Francis, 2002).
It has long been known that successful
angiogenesis is required for sustained
growth of virtually all solid tumors. Recent
studies, however, have also demonstrated the
importance of angiogenesis in normal
hematopoietic cell development as well as in
the pathophysiology of several hematologic
malignancies including leukemias (Shanafelt
and Kay, 2006). Among the different
experimental models exploited to investigate
leukemias, Friend erythroleukemia cells are
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considered a model system for understanding
the physiopathology of human leukemia, the
multistage nature of leukemogenesis, and the
molecular mechanisms of leukemia
resistance (Smadja-Joffe et al., 1975; Ney
and D’Andrea, 2000). Nonetheless, the
relationship between Friend erythroleukemia
and angiogenesis has not yet been studied.
Based upon these assumptions, we
studied the angiogenic response induced by
Friend erythroleukemia cells in two well-
established models for angiogenesis
investigation,  i.e.,  the chick embryo
Chorioallantoic Membrane (CAM) assay and
Human Umbilical Vein Endothelial Cells
(HUVEC) cultures. Given the fundamental
role of prostaglandins in the control of
angiogenesis, one of these signaling
molecules (PGE1) was used as control. The
use of CAM as a model system also allowed
discrimination between the observed effects
of Friend erythroleukemia cells and of PGE1
on angiogenesis vs vasculogenesis. Thus,
observation of the growing embryo allowed
the determination of whether the different
substances tested affected vasculogenesis,
compromising its viability, or selectively
affected angiogenesis.
MATERIALS AND METHODS
Friend erythroleukemia cells (ATCC,
Manassas, VA, USA) were routinely
maintained in culture medium (Cataldi et
al., 2003); briefly, RPMI-1640 medium
(Gibco, Milan, Italy) was supplemented
with 10% Fetal Calf Serum (FCS) (Gibco,
Milan, Italy) and 1% penicillin (10,000 U/
ml)/streptomycin (l0 mg/ml) (Gibco, Milan,
Italy), at 37°C in a controlled atmosphere
with 5% CO2.
HUVEC (ATCC, Manassas, VA, USA)
were routinely maintained in complete
culture medium containing: endothelial
basal growth medium (EBM-2) with 2%
fetal bovine serum (FBS), 0.4% human
FGF-B, 0.1% VEGF, 0.1% recombinant
long R Insulin-like Growth Factor-B (R3-
IGF-1), 0.1% human Epidermal Growth
Factor (h-EGF), 0.1% gentamicin sulfate
(GA-1000), 0.04% hydrocortisone, 0.1%
ascorbic acid, and 0.1% heparin. All these
culture medium components were from
Cambrex Bio Science, Milan, Italy.
HUVEC were seeded in cell-culture
flasks coated with 0.2% gelatin (Sigma
Chemical Co., Milan, Italy), at 37°C in a
controlled atmosphere with 5% CO2.
3x107 Friend erythroleukemia cells were
placed in 75 cm2 culture flasks without FCS
and incubated for 48 h. At the end of
incubation, conditioned medium (CM) was
collected, sequentially centrifuged at 3,000
and 15,000 g for 10 min, respectively, and
filtered through 0.22 μm pore-size filters
(Ribatti et al., 1998).
CAM assay
The CAM is an extra-embryonic membrane,
which serves as a gas exchange surface
(Romanoff, 1960). Its respiratory function
is provided through an extensive capillary
network. CAM is formed on the fourth day
of incubation by the fusion of the
ectodermal epithelium (chorion) and the
endodermal epithelium (allantois). At this
stage, undifferentiated blood vessels are
scattered in the mesoderm of the CAM.
They grow very rapidly until day 8, when
some vessels differentiate into capillaries
and form a layer at the base of the
ectoderm. At day 14, 6 days before
hatching, the capillary plexus is located at
the surface of the ectoderm, adjacent to the
shell membrane (Ausprunk et al., 1974;
1977). The CAM includes the
chorioallantoic fluid into which waste
products are delivered. Because of its
extensive vascularization, CAM has been
widely utilized as an in vivo model for the
evaluation of angiogenic and anti-
angiogenic molecules (Wilting et al., 1991;
Ribatti et al., 1999).
For the CAM assays, fertilized white
Leghorn chicken eggs were incubated under
routine conditions (i .e.,  60% relative
humidity at 37.5°C), and a square window
of approximately 7 cm2 was opened in the
egg shell at day 3 of incubation, after
removal of 3.5 ml of albumen to detach the
shell from the developing CAM. The
window was sealed with a glass, and the
eggs were returned to the incubator. Gelatin
sponges (Upjohn Company, Kalamazoo,
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USA) were cut to a size of less than 1 mm3
and placed on the top of the CAM at day 8
under sterile conditions (Ribatti et al.,
1997). The sponges (1/egg) were then
soaked with 5 μl of tested compounds such
as Phosphate Buffered Saline (PBS), PGE1
and CM. PGE1 (0.001-10 mg/ml) was used
as positive control to induce angiogenesis.
CM was tested at different dilutions (i.e.,
undiluted or diluted in culture medium at
1:10, 1:100, 1:1000). In each experiment,
we used 6 eggs for experimental point (i.e.,
6 eggs treated with PBS, 6 eggs treated with
PGE1, and so on). Each experiment was
repeated 3 times; thus, 18 eggs per
experimental point were scored.
CAMs were examined daily and
photographed in ovo at day 12 (Fig. 1). Eggs
were examined by stereomicroscopy, and
positive angiogenesis was considered if new
microvessels (in particular, microvessels
surrounding the sponge, defined as
circumfocal microvessels) had developed.
Live images of the CAM were captured
using a high-resolution digital camera
connected with the stereomicroscope. Fig. 1
depicts examples of the angiogenic response
of the CAM after implantation of gelatin
sponges soaked with different substances. In
each panel of Fig. 1, we report the picture of
a single egg, representative of 18 treated in
the same manner.
Figure 1: Angiogenic response of the chick embryo Chorioallantoic Membrane (CAM) after
implantation of gelatin sponges soaked with different substances.
Panel A: PBS, negative control. A weak vascular reaction was detectable around the sponge.
Panel B: PGE1 (1 mg/ml), positive control. A strong angiogenic response with numerous allantoic
vessels developing radially towards the implant was observed.
Panel C: undiluted CM of Friend erythroleukemia cells. A strong angiogenic response comparable
to that induced by PGE1 was detectable.
Panel D: PGE1 (1 mg/ml) plus undiluted CM of Friend erythroleukemia cells. The angiogenic
response was similar to that observed with undiluted CM or PGE1 (1 mg/ml) alone.
Solid arrowheads indicate the gelatin sponges. Open arrowheads indicate major blood vessels. Solid
arrows indicate newly formed, angiogenic blood vessels. Total magnification: x25. Scale bar: 0.4
mm. The circle around each sponge indicates the circumfocal area where microvessels were scored.
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Captured images were digitized and
analyzed for the number of angiogenic
blood vessels (i.e., those surrounding the
sponges),  using a customized image-
analysis software program (Scion
Corporation, Frederick, MD, USA). Small
(diameter < 1 mm), large (diameter > 1
mm), and tortuous microvessels were
observed at different magnifications.
Angiogenesis was assessed by scoring
the Circumfocal Microvessel Number
(CFMN), following the procedure recently
validated (Sharma et al., 2001). The area
surrounding the sponges where CFMN was
scored is indicated by a circle in each panel
of Fig. 1. Since the CAM is an anatomical
structure similar to a disc about 400 μm
thick, all the angiogenic vessels within the
circumfocal area could be scored as if they
were on a flat surface (Ribatti et al., 1997;
Sharma et al., 2001). Observers (2 for each
experiment) were blinded with regard to the
experimental conditions.
Quantitative evaluation of angiogenesis,
expressed as CFMN, induced by each
compound is shown in Table I.
HUVEC proliferation was monitored as
incorporation of [3H]thymidine in
duplicating DNA and measured by liquid
scintillation after a 4 h pulse of
[3H]thymidine (Love-Schimenti et al.,
1996; Pacini et al. ,  1999). Each
experimental point was performed in
triplicate samples. At sub-confluence, the
medium was changed, and HUVEC were
maintained in medium without 2% FBS,
0.4% h-FGF-B, 0.1% VEGF, 0.1% R3-IGF-
1, 0.1% h-EGF, 0.1% GA-1000 (i.e., EBM-
2 supplemented with hydrocortisone,
ascorbic acid and heparin) for 48 h.
Afterward, the cells were challenged for 24
h with PBS or FBS (10%) or undiluted CM
Friend erythroleukemia cells or undiluted
CM Friend erythroleukemia cells plus FBS
(10%). For the dose-dependence curve, the
endothelial cell medium was replaced with
different dilutions of CM (i.e., undiluted or
diluted at 1:10, 1:100, 1:1000); for the
time-dependence curve, cells were pulse-
labeled with [3H]thymidine after 24, 48,
and 72 h stimulation as described (Love-
Schimenti et al., 1996). In both cases, 3[H]
radioactivity was measured as count per
minute (cpm) by liquid scintillation
counting.
Differences between continuous
variables were examined by Student’s t test.
Differences were considered statistically
significant when p < 0.02.
RESULTS AND DISCUSSION
Friend erythroleukemia is considered a
model system for the understanding of
multistage carcinogenesis (Ney and
D’Andrea, 2000) and tumor progression
(Tambourin et al., 1991). Since both
processes require successful angiogenesis
(Bergers et al., 1999; Moehler et al., 2003;
TABLE I
Chick embryo Chorioallantoic Membrane (CAM) assay
CFMN S.E.M. %
PBS 20.2 0.47 100
PGE1 34.0* 0.99 168
Undiluted CM Friend erythroleukemia cells 37.5* 0.92 186
Undiluted CM Friend erythroleukemia cells + PGE1 34.7* 0.61 172
The number of angiogenic blood vessels, expressed as CFMN, derived from scoring small (diameter < 1 mm),
large (diameter > 1 mm), and tortuous microvessels is reported for each experimental point. Undiluted CM of
Friend erythroleukemia cells was prepared as described in the Materials and Methods section. Data are
reported as means ± S.E.M. (n=18). * indicates significant difference from PBS (p < 0.02).
113PACINI ET AL. Biol Res 41, 2008, 109-117
Moheler et al., 2004; Molica et al., 2004),
first we tested the angiogenic effect of CM
from Friend erythroleukemia cells in the
CAM assay (Table I and Fig. 1). Angiogenic
response could be quantitatively scored as
described in the Materials and Methods
section.
In the specimens treated with PBS as
negative control, only a weak vascular
reaction was detectable around the sponges
(Table I and Fig. 1A). PGE1, a known
stimulator of angiogenesis, elicited a dose-
dependent response of the developing
vasculature of the CAM (Fig. 2). Fig. 1B
shows the effects of PGE1 at 1 mg/ml
concentration, i.e., a concentration that
elicited maximal response: blood vessels
with an irregular course and frequent
branching were observed; the gelatin
sponges were surrounded by allantoic
vessels that developed radially towards the
implant in a radial pattern.
Undiluted CM of Friend erythroleukemia
cells stimulated angiogenesis to an extent
comparable to the maximal effect achieved
by PGE1 (Table I, Fig. 1C). The stimulatory
effect of CM was concentration-dependent,
as shown in Fig. 3, reporting data from
experiments where different dilutions of CM
were tested. These results could be explained
considering that Friend erythroleukemia
cells may produce and secrete growth factors
stimulating angiogenesis in analogy to what
observed in other leukemic cell types (Ruan
et al., 2001; Ebos et al., 2002). PGE1 (1 mg/
ml) added to the undiluted CM of Friend
erythroleukemia cells did not significantly
increase angiogenesis (Table I and Fig. 1D),
as if maximal response in the CAM assay
had been reached.
The results observed in the CAM assay
were replicated in another experimental
model widely used in studying angiogenesis,
i.e., proliferation in HUVEC measured as
[3H]thymidine incorporation (Table II).
HUVEC treatment with PBS and FBS as
negative and positive control, respectively,
and with undiluted CM of Friend
erythroleukemia cells, was analogous to that
described in the CAM assay. 10% FBS
Figure 2: PGE1-induced angiogenesis in the chick embryo Chorioallantoic Membrane (CAM)
assay.
The number of angiogenic blood vessels derived from scoring small (diameter < 1 mm), large
(diameter > 1 mm), and tortuous microvessels is reported for each experimental point. Data are
reported as means ± S.E.M. (n=18).
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stimulated HUVEC proliferation (Table II)
to an extent similar to that observed studying
angiogenesis in the CAM assay after
stimulation with PGE1 (Table I). Undiluted
CM of Friend erythroleukemia cells induced
a strong HUVEC proliferation. The effect of
CM was dose- and time-dependent (Fig. 4A
and B) and comparable to that induced by
positive control (Table II). Overall, these
results were consistent with those observed
in the CAM assay after undiluted CM
stimulation (Table I). Just as observed in the
CAM assay, undiluted CM added to positive
control (FBS) did not significantly increase
HUVEC proliferation as compared to the
proliferative effects induced by undiluted
CM and positive control tested separately
(Table II).
In this study, we demonstrate that CM of
Friend erythroleukemia cells stimulated
HUVEC proliferation and angiogenesis in
chick embryo. Friend erythroleukemia cells,
similar to several other transformed cell
types, may produce and secrete growth
factors stimulating angiogenesis and
proliferation of endothelial cells (Ruan et
al., 2001; Ebos et al., 2002). To our
knowledge, this is the first observation
concerning Friend erythroleukemia cells
and angiogenesis.
In addition, the observed normal
development of the embryo suggests that
CM of Friend erythroleukemia cells did not
alter the process of vasculogenesis. Indeed,
vasculogenesis is a biological process
occurring during embryo development in
which new blood vessels originate from
endothelial cell precursors, and it is unlike
angiogenesis, in which new blood vessels
originate from pre-existing blood vessels
(Yancopoulos et al., 1998). Successful
vasculogenesis is essential for normal
embryo development and viability (Flamme
et al., 1997).
Figure 3: CM-induced angiogenesis in the chick embryo Chorioallantoic Membrane (CAM) assay.
CM of Friend erythroleukemia cells was added at the dilution indicated in the horizontal axis. 0
indicates the absence of CM; 1:1 indicates undiluted CM. The number of angiogenic blood vessels
(vertical axis) derived from scoring small (diameter < 1 mm), large (diameter > 1 mm), and
tortuous microvessels is reported for each experimental point. Data are reported as means ± S.E.M.
(n=18).
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Figure 4: Human Umbilical Vein Endothelial Cells (HUVEC) proliferation.
HUVECs were challenged with CM of Friend erythroleukemia cells at the dilution indicated in the
horizontal axis (Panel A). 0 indicates the absence of CM; 1:1 indicates undiluted CM. Undiluted
CM was tested for different time intervals as indicated in Panel B. HUVEC proliferation was
assessed by measuring incorporation of [3H]thymidine in duplicating DNA by liquid scintillation
after a 4 h pulse of [3H]thymidine. Each point (cpm, as indicated in the vertical axis) represents the
means of triplicate samples + S.E.M.
Panel A
Panel B
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The absence of harmful side effects on
chick embryo development and viability
observed in our study demonstrates that
physiological vasculogenesis of developing
embryos was unaffected by CM of Friend
erythroleukemia cells. The observed
selectivity of effect  (i.e., stimulation of
angiogenesis without affecting physiological
vasculogenesis of developing embryos)
holds great promise for development of
therapeutic candidates that could selectively
target leukemia-associated angiogenesis.
This could be important because, beside its
role during development, vasculogenesis
contributes to the formation of new blood
vessels in adults after tissue ischemia
(Walter and Dimmeler, 2002), and its
inhibition would be harmful, in particular for
patients with concurring ischemic diseases.
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TABLE II
Human Umbilical Vein Endothelial Cells (HUVEC) proliferation study
Cpm S.E.M. %
PBS 550 20 100
FBS 1081* 180 196
Undiluted CM Friend erythroleukemia cells 1005* 193 183
Undiluted CM Friend erythroleukemia cells + FBS 1038* 185 189
HUVECs after 48 h starvation were challenged for 24 h with PBS or FBS. In the experiments in which
undiluted CM of Friend erythroleukemia cells were tested, the endothelial cell medium was completely
replaced with undiluted CM or with undiluted CM plus FBS. HUVEC proliferation was assessed by
measuring incorporation of [3H]thymidine in duplicating DNA by liquid scintillation after a 4 h pulse of
[3H]thymidine. Each point represents the mean of triplicates + S.E.M. * indicates significant difference from
PBS (p < 0.02).
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